论文信息 - Model of three‐dimensional structure of vitamin D receptor and its binding mechanism with 1α,25‐dihydroxyvitamin D3

Model of three‐dimensional structure of vitamin D receptor and its binding mechanism with 1α,25‐dihydroxyvitamin D3

Comparative modeling of the vitamin D receptor three‐dimensional structure and computational docking of 1α,25‐dihydroxyvitamin D3 into the putative binding pocket of the two deletion mutant receptors: (207–423) and (120–422, Δ [164–207]) are reported and evaluated in the context of extensive mutagenic analysis and crystal structure of holo hVDR deletion protein published recently. The obtained molecular model agrees well with the experimentally determined structure. Six different conformers of 1α,25‐dihydroxyvitamin D3 were used to study flexible docking to the receptor. On the basis of values of conformational energy of various complexes and their consistency with functional activity, it appears that 1α,25‐dihydroxyvitamin D3 binds the receptor in its 6‐s‐trans form. The two lowest energy complexes obtained from docking the hormone into the deletion protein (207–423) differ in conformation of ring A and orientation of the ligand molecule in the VDR pocket. 1α,25‐Dihydroxyvitamin D3 possessing the A‐ring conformation with axially oriented 1α‐hydroxy group binds receptor with its 25‐hydroxy substituent oriented toward the center of the receptor cavity, whereas ligand possessing equatorial conformation of 1α‐hydroxy enters the pocket with A ring directed inward. The latter conformation and orientation of the ligand is consistent with the crystal structure of hVDR deletion mutant (118–425, Δ [165–215]). The lattice model of rVDR (120–422, Δ [164–207]) shows excellent agreement with the crystal structure of the hVDR mutant. The complex obtained from docking the hormone into the receptor has lower energy than complexes for which homology modeling was used. Thus, a simple model of vitamin D receptor with the first two helices deleted can be potentially useful for designing a general structure of ligand, whereas the advanced lattice model is suitable for examining binding sites in the pocket. Proteins 2001;44:188–199. © 2001 Wiley‐Liss, Inc.

[1] D. Gardner,et al. Coactivator-Vitamin D Receptor Interactions Mediate Inhibition of the Atrial Natriuretic Peptide Promoter* , 2000, The Journal of Biological Chemistry.

[2] Andrzej Kolinski,et al. Protein Folding: Flexible Lattice Models , 2000 .

[3] K. Umesono,et al. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4] D. Moras,et al. Large-scale expression and purification of the human vitamin D receptor and its ligand-binding domain for structural studies. , 1999, The Biochemical journal.

[5] T. Craig,et al. Analysis of transcription complexes and effects of ligands by microelectrospray ionization mass spectrometry , 1999, Nature Biotechnology.

[6] H. DeLuca,et al. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1α, 25-dihydroxyvitamin D3 , 1999 .

[7] P Rotkiewicz,et al. A method for the improvement of threading‐based protein models , 1999, Proteins.

[8] R. Fletterick,et al. Three‐dimensional model of the ligand binding domain of the nuclear receptor for 1α,25‐dihydroxy‐vitamin D3 , 1999 .

[9] J. Lehmann,et al. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10] R. K. DeLisle,et al. The Autonomous Transactivation Domain in Helix H3 of the Vitamin D Receptor Is Required For Transactivation and Coactivator Interaction* , 1999, The Journal of Biological Chemistry.

[11] K. Umesono,et al. Three-dimensional structure-function relationship of vitamin D: side chain location and various activities. , 1999, Bioorganic & medicinal chemistry letters.

[12] H. DeLuca,et al. Bacterial expression and characterization of the ligand-binding domain of the vitamin D receptor. , 1999, Archives of Biochemistry and Biophysics.

[13] J. Rouvinen,et al. Putative helices 3 and 5 of the human vitamin D3 receptor are important for the binding of calcitriol , 1998, FEBS letters.

[14] H. DeLuca,et al. Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.

[15] J. Skolnick,et al. Assembly of protein structure from sparse experimental data: An efficient Monte Carlo model , 1998, Proteins.

[16] P. Sigler,et al. Atomic structure of progesterone complexed with its receptor , 1998, Nature.

[17] S. Yamada,et al. Conformation-function relationship of vitamin D: conformational analysis predicts potential side-chain structure. , 1998, Journal of medicinal chemistry.

[18] S. Peleg,et al. Differential use of transcription activation function 2 domain of the vitamin D receptor by 1,25-dihydroxyvitamin D3 and its A ring-modified analogs. , 1998, Molecular endocrinology.

[19] N. Swamy,et al. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent. , 1997, Archives of biochemistry and biophysics.

[20] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[21] C. Carlberg,et al. Functional conformations of the nuclear 1alpha,25-dihydroxyvitamin D3 receptor. , 1997, The Biochemical journal.

[22] R. St-Arnaud,et al. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. , 1997, Molecular endocrinology.

[23] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[24] H. DeLuca,et al. The Vitamin D Receptor—Structure and Transcriptional Activation , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25] M. Haussler,et al. Mutations in the 1,25-Dihydroxyvitamin D3 Receptor Identifying C-terminal Amino Acids Required for Transcriptional Activation That Are Functionally Dissociated from Hormone Binding, Heterodimeric DNA Binding, and Interaction with Basal Transcription Factor IIB, in Vitro * , 1997, The Journal of Biological Chemistry.

[26] A. Norman,et al. Differential Interaction of 1α,25-Dihydroxyvitamin D3 Analogues and Their 20-epi Homologues with the Vitamin D Receptor* , 1997, The Journal of Biological Chemistry.

[27] R. Bouillon,et al. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. , 1997, The Journal of clinical investigation.

[28] M. Galligan,et al. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. , 1996, Molecular endocrinology.

[29] L. Wheeler,et al. T4 Phage Gene 32 Protein as a Candidate Organizing Factor for the Deoxyribonucleoside Triphosphate Synthetase Complex (*) , 1996, The Journal of Biological Chemistry.

[30] M. Galligan,et al. Examination of the Potential Functional Role of Conserved Cysteine Residues in the Hormone Binding Domain of the Human 1,25-Dihydroxyvitamin D Receptor (*) , 1996, The Journal of Biological Chemistry.

[31] M. Haussler,et al. Affinity Labeling of the 1,25-Dihydroxyvitamin D Receptor (*) , 1996, The Journal of Biological Chemistry.

[32] William Bourguet,et al. A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.

[33] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.

[34] Mary E. McGrath,et al. A structural role for hormone in the thyroid hormone receptor , 1995, Nature.

[35] G. Whitfield. "A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation". , 1995, Molecular endocrinology.

[36] M. Haussler,et al. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. , 1995, Molecular endocrinology.